Valuation: Principal Technologies Inc.

Market Cap 18.08M 12.68M 11.27M 10.52M 9.59M 1.22B 18.25M 127M 49.32M 623M 47.62M 46.58M 2B P/E 2024 *
-
P/E 2025 -2x
Enterprise Value 17.08M 11.98M 10.64M 9.93M 9.05M 1.15B 17.24M 120M 46.58M 589M 44.97M 44M 1.89B EV / Sales 2024
7,172,726x
EV / Sales 2025 25,290,400x
Free-Float
66.21%
Yield 2024 *
-
Yield 2025 -
3 years 0
Extreme 0
0.27
5 years 0
Extreme 0
0.27
10 years 0
Extreme 0
0.27
Manager TitleAgeSince
Chief Executive Officer 47 03/08/2021
Director of Finance/CFO 70 05/03/2023
Director TitleAgeSince
Director/Board Member 70 03/08/2021
Chairman 55 -
Director/Board Member 47 03/08/2021
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--% - - 13.53M
+4.16%+3.04%+49.37%+94.17% 74.41B
-3.11%-3.53%+21.92%+74.60% 59.26B
+0.89%-0.63%+4.28%+34.51% 47.14B
-0.61%-4.40%+26.49%+33.31% 42.91B
+0.32%+0.27%+349.74%+685.36% 44.13B
-0.94%-1.77%+2.70%+98.59% 40.79B
-0.54%+2.93%+9.50%+50.41% 30.77B
-2.68%+5.11%+33.11%+19.50% 29.31B
+2.23%-5.76%-27.33%+337.68% 23.71B
Average -0.05%-0.64%+52.20%+158.68% 43.6B
Weighted average by Cap. +0.17%-0.40%+57.26%+150.04%

Financials

2024 2025
Net sales 0.66 0.47 0.41 0.39 0.35 44.78 0.67 4.67 1.81 22.89 1.75 1.71 73.47 0.37 0.26 0.23 0.22 0.2 24.98 0.37 2.61 1.01 12.77 0.98 0.95 40.98
Net income -1.62M -1.13M -1.01M -940K -856K -109M -1.63M -11.37M -4.41M -55.68M -4.25M -4.16M -179M -4.24M -2.97M -2.64M -2.46M -2.25M -286M -4.27M -29.82M -11.55M -146M -11.15M -10.91M -469M
Net Debt -767K -538K -478K -446K -407K -51.75M -775K -5.4M -2.09M -26.46M -2.02M -1.98M -84.91M -1M -704K -625K -583K -532K -67.64M -1.01M -7.06M -2.74M -34.58M -2.64M -2.58M -111M
Logo Principal Technologies Inc.
Principal Technologies Inc. is a Canada-based healthcare acquisition company. The Company is engaged in building a diverse portfolio of investments in healthcare technology companies with a focus on those with global distribution potential which have intellectual property capable of enhancing medical treatment quality, cost efficiency, optimization of the patient pathway, and implementation of point of care technologies. The Company operates through the health-care technology segment, including the project management of international scale clinical studies primarily related to medical device technologies. Its subsidiaries include Principal Technologies Capital Management GmbH and E&E CRO Consulting GmbH.
Employees
-